Olmesartan Medoxomil is used for: Hypertension; Diabetic nephropathy.
Recorded in the NepalDoc medicine catalog for Olmesartan Medoxomil.
Olmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
From the U.S. FDA-approved label for Olmesartan Medoxomil. Full label: DailyMed.
Olmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals.
From the U.S. FDA-approved label for Olmesartan Medoxomil. Full label: DailyMed.
The recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 40/12.5 mg once daily in patients whose blood pressure is not adequately controlled with olmesartan monotherapy. Dose can be titrated up to 40 /25 mg if necessary. The recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 20/12.5 mg once daily in patients whose blood pressure is not adequately controlled with HCT monotherapy or who experience dose-limiting adverse reactions with hydrochlorothiazide.
Directions from the U.S. FDA-approved label for Olmesartan Medoxomil — your doctor or pharmacist may advise differently.
Olmesartan medoxomil and hydrochlorothiazide is contraindicated: In patients with hypersensitivity to any component of olmesartan medoxomil and hydrochlorothiazide In patients with anuria For coadministration with aliskiren in patients with diabetes. Hypersensitivity to any component of olmesartan medoxomil and hydrochlorothiazide Anuria Do not co-administer aliskiren with olmesartan medoxomil and hydrochlorothiazide in patients with diabetes.
Excerpt from the U.S. FDA-approved label for Olmesartan Medoxomil. Talk to a pharmacist or doctor before use.
Hypotension: Correct volume-depletion prior to administration. Monitor renal function and potassium in susceptible patients Observe for signs of fluid or electrolyte imbalance. Acute angle-closure glaucoma Sprue-like enteropathy has been reported. Consider discontinuation of olmesartan medoxomil and hydrochlorothiazide in cases where no other etiology is found 5.1 Fetal Toxicity Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.
Warnings and precautions excerpt from the U.S. FDA-approved label for Olmesartan Medoxomil — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions with olmesartan medoxomil and hydrochlorothiazide are described elsewhere: Hypotension in Volume- or Salt-Depleted Patients Impaired Renal Function Hypersensitivity Reactions Electrolyte and Metabolic Imbalances Acute Myopia and Secondary Angle-Closure Glaucoma Systemic Lupus Erythematosus Sprue-Like Enteropathy Most common adverse reactions (incidence ≥2%) are nausea, hyperuricemia, dizziness,…
Excerpt from the U.S. FDA-approved label for Olmesartan Medoxomil — not a complete list. Talk to a pharmacist or doctor about side effects.
18 brands · 8 makers in the NepalDoc catalog — see the full Olmesartan Medoxomil guide →
What is Olmat?
Olmat 40mg Tablet is a Olmesartan Medoxomil medicine made by Micro Labs Ltd. It comes as 40mg Tablet.
What is Olmat used for?
Olmesartan Medoxomil is used for Hypertension, Diabetic nephropathy.
What is the generic name of Olmat?
The generic name of Olmat is Olmesartan Medoxomil.
Which brands of Olmesartan Medoxomil are available in Nepal?
18 brands of Olmesartan Medoxomil are listed in the NepalDoc catalog, from 8 makers — including Benitec 20mg Tablet, Olace 10mg Tablet, Olace 20mg Tablet, Olace 40mg Tablet, Olmat 20mg Tablet, Olmecip 20mg Tablet.
What are the side effects of Olmesartan Medoxomil?
The following adverse reactions with olmesartan medoxomil and hydrochlorothiazide are described elsewhere: Hypotension in Volume- or Salt-Depleted Patients Impaired Renal Function Hypersensitivity Reactions Electrolyte and Metabolic Imbalances Acute Myopia and Secondary Angle-Closure Glaucoma Systemic Lupus Erythematosus Sprue-Like Enteropathy Most common adverse reactions (incidence ≥2%) are nausea, hyperuricemia, dizziness,…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
